Thomas F. Keller is Director at BIOGEN IDEC INC. (BIIB). They have made 1 open-market trade across 1 company since 2004, most recently 2008-09-29.
CIK 0001013672
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BIIB | SELL · 10b5-1 | 2007-10-15 | 2007-10-17 | $82.00 | $849K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2007-08-24 | 2007-08-27 | $62.00 | $428K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2006-11-01 | 2006-11-02 | $48.00 | $166K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2006-09-01 | 2006-09-05 | $44.60 | $308K | -11.0% | -1.9% | -1.9% |
| WEN | SELL | 2006-05-11 | 2006-05-15 | $62.28 | $1.2M | -7.9% | +0.6% | +0.6% |
| BIIB | SELL · 10b5-1 | 2006-03-31 | 2006-04-04 | $46.95 | $486K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2004-10-01 | 2006-11-08 | $61.00 | $631K | -11.0% | -1.9% | -1.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.